Prepare for Neuromuscular Blocker Vials without Cap Warnings

Due to shortages of neuromuscular blocking agents needed for critically ill COVID-19 patients, the FDA has allowed temporary manufacture of these drugs without the usual statement: “Warning: Paralyzing Agent” on the vial cap. The lack of a warning statement may make vials look similar to other medications and lead to possible confusion and errors. For ISMP recommendations to avoid mix-ups and ensure safe storage, visit: https://ismp.org/node/18346